CRL
Charles River Laboratories International, Inc.Pharmaceuticals, Biotechnology & Life Sciences
- Rank · 2026
- #372
- Final score
- 55.15
- Years on list
- 7
↗ Climbed 203 since 2020
Compare · Up to four Russell 1000 companies
Select two, three, or four Russell 1000 companies to compare their overall rank, year-by-year trajectory, and scores down to the category level.
Figure 01 · Side-by-side summary
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 203 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 261 since 2020
Pharmaceuticals, Biotechnology & Life Sciences
↗ Climbed 604 since 2022
Figure 02 · Rank trajectory
Lower is better. The y-axis is inverted so a rising line means an improving rank. Missing years mean the company didn't make the top 100 that year.
Figure 03 · Pillar profile · 2026
Latest-year ESG pillar scores, 0–100. The shaded bar shows relative strength across the selected companies for each pillar.
| Pillar | CRL | ZTS | NTRA |
|---|---|---|---|
| Climate Change | 56.8 | 63.7 | 79.6 |
| Employee Relations | 63.5 | 51.8 | 54.5 |
| Environment | 41.7 | 57.1 | 53.0 |
| Stakeholders & Society | 66.0 | 50.6 | 21.1 |
| Human Rights | 49.0 | 45.6 | 50.8 |
| Governance | 50.6 | 68.2 | 52.1 |
| Performance Rating | 56.5 | 51.3 | 67.5 |